ByNobleID
    PUK8 THE COST-EFFECTIVENESS OF PARICALCITOL VERSUS STANDARD TREATMENT FOR SECONDARY HYPERPARATHYROIDISM – MULTICOUNTRY PERSPECTIVES | NobleID